Chinese english Germany Japanese Korea

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel Struktur
2251812-53-8
CAS-Nr.
2251812-53-8
Englisch Name:
1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel
Synonyma:
1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel
CBNumber:
CB811557793
Summenformel:
C10H15N7O9S2
Molgewicht:
441.39
MOL-Datei:
2251812-53-8.mol
Request For Quotation

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel Eigenschaften

Sicherheit

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel Chemische Eigenschaften,Einsatz,Produktion Methoden

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
  • 1H-4,7-Methanopyrazolo[3,4-e][1,3]diazepine8-carboximidic acid, 4,5,6,8-tetrahydro-1- methyl-6-oxo-N,5-bis(sulfooxy)-, 8-(1- methylhydrazide), [C(Z),4R,7R,8S]-rel
  • 2251812-53-8
Copyright 2019 © ChemicalBook. All rights reserved